Novavax’s Pfizer Matrix-M licensing deal brings $30M upfront, milestones & royalties. Read the full analysis here.
The Food and Drug Administration on Wednesday approved the latest round of Covid vaccines in the U.S., but only for those at higher risk of getting severely sick from the virus. Health and Human ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results